Financial Ratios

GUJARAT TERCE LABORATORIES LTD.

NSE : NABSE : 524314ISIN CODE : INE499G01013Industry : Pharmaceuticals & DrugsHouse : Private
BSE66.883.18 (+4.99 %)
PREV CLOSE ( ) 63.70
OPEN PRICE ( ) 66.87
BID PRICE (QTY) 66.88 (63648)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 59088
TODAY'S LOW / HIGH ( )66.87 66.88
52 WK LOW / HIGH ( ) 16.6570.91
NSE
This Company is not listed in NSE
Select year
ParticularsMar2023Mar2022Mar2021Mar2020Mar2019
Operational & Financial Ratios
   Earnings Per Share (Rs)-2.251.18-3.400.370.58
   CEPS(Rs)-1.761.55-3.160.700.87
   DPS(Rs)0.000.000.000.000.00
   Book NAV/Share(Rs)9.2511.5010.3314.9714.60
   Tax Rate(%)42.24-16.840.4536.64-25.10
Margin Ratios
   Core EBITDA Margin(%)-4.622.78-10.991.821.57
   EBIT Margin(%)-4.642.86-8.501.941.93
   Pre Tax Margin(%)-6.191.86-10.051.161.11
   PAT Margin (%)-3.572.17-10.010.741.39
   Cash Profit Margin (%)-2.792.86-9.311.382.08
Performance Ratios
   ROA(%)-6.183.58-11.441.332.23
   ROE(%)-21.7110.77-26.852.524.07
   ROCE(%)-14.818.31-16.405.775.38
   Asset Turnover(x)1.731.651.141.801.60
   Sales/Fixed Asset(x)5.635.564.116.415.72
   Working Capital/Sales(x)-83.5117.7580.8514.3112.17
Efficiency Ratios
   Fixed Capital/Sales(x)0.180.180.240.160.17
   Receivable days52.5148.4388.3056.0753.58
   Inventory Days42.3746.2551.9935.0544.51
   Payable days99.1087.45113.8983.1697.13
Valuation Parameters
   PER(x)0.0022.240.0017.0115.61
   PCE(x)-9.4616.90-2.209.0710.49
   Price/Book(x)1.802.270.670.420.62
   Yield(%)0.000.000.000.000.00
   EV/Net Sales(x)0.380.650.340.190.23
   EV/Core EBITDA(x)-9.7418.31-4.397.488.94
   EV/EBIT(x)-8.1022.71-4.029.9712.09
   EV/CE(x)0.650.960.400.320.37
   M Cap / Sales0.260.480.210.130.22
Growth Ratio
   Net Sales Growth(%)16.5759.40-32.9420.996.95
   Core EBITDA Growth(%)-227.01172.47-302.6819.5110.12
   EBIT Growth(%)-289.31153.61-394.1821.358.76
   PAT Growth(%)-291.63134.61-1012.54-36.1559.74
   EPS Growth(%)-291.62134.61-1012.54-36.1559.74
Financial Stability Ratios
   Total Debt/Equity(x)1.060.780.620.230.06
   Current Ratio(x)0.971.171.031.281.38
   Quick Ratio(x)0.700.680.710.910.82
   Interest Cover(x)-3.012.86-5.472.492.36
   Total Debt/Mcap(x)0.590.340.920.550.10

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.